Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 220   

Articles published

PFE 33.76 +0.02 (0.06%)
price chart
The US Intravenous Saline Solution Probe Summons Pfizer Inc (NYSE:PFE ...
The news just trickling in have made clear the fact that Pfizer Inc (NYSE:PFE) has indeed received a grand jury subpoenas from the United State's Justice Department in line with an antitrust investigation narrowing down on drug makers that market and ...
Pfizer Inc. (PFE) Closes 0.06% Up on the Day for April 25
Shares of Pfizer Inc. (PFE) ended the trading day Tuesday at $33.76, representing a move of 0.06%, or $0.02 per share, on volume of 18.54 million shares.
Pfizer Inc. (PFE) has a 52-week low of $29.24  StandardOracle
West Family Investments Inc. Has $2736000 Position in Pfizer Inc. (PFE)  The Cerbat Gem
Chart Revelations As Seen From Pfizer Inc. (PFE)
The technicals for Pfizer Inc. (PFE) has spoken via its technical chart and the message is loud and clear. Based on that message, this is the relevant information necessary to make sense of that current setup.
EOD Risers: Microsoft Corporation, Pfizer Inc., Procter & Gamble Co, The Coca ...
Shares of Pfizer Inc. with company EPIC: (NYSE:PFE) a research-based global biopharmaceutical company, stepped up 0.3% or 0.1 points during yesterday's session.
The 3 Most Important Numbers for Pfizer Inc.
From the company's accumulated post-retirement benefit obligation to Zoloft revenue, there are a lot of numbers involved in understanding Pfizer's business. But I think that there are three numbers that are most important to Pfizer. What are the numbers?
Pfizer Inc. (PFE) Closes 0.3% Up on the Day for April 24
Shares of Pfizer Inc. (PFE) ended the trading day Monday at $33.74, representing a move of 0.3%, or $0.1 per share, on volume of 20.67 million shares.
The Markets Are Undervaluing these stock's: Pfizer Inc. (PFE), The Coca ...  StockNewsJournal
Pfizer: Relatively High Yield Healthcare Blue Chip  Seeking Alpha
The Technical Chart For Pfizer Inc. (PFE) Has Spoken
Pfizer Inc. (PFE) has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.
Pfizer Receives Positive CHMP Opinion for BESPONSA� (Inotuzumab Ozogamicin ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of BESPONSA� ...
Pfizer Unveils ATLAS�, An Interactive, User-Friendly Website That Provides ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced the launch of the company's Antimicrobial Testing Leadership and Surveillance (ATLAS) website, which is designed to provide physicians and the global health community with easy access to ...
Pfizer Inc. performed Very Well with a change of 0.3% in the Last Trade
Currently, the market capitalization of Pfizer Inc. (PFE) is 200.93 Billion. PFE has a 1-year high price of $ 36.35 and 1-year low price of $29.24.